DOJ Sues Healthpoint Over Zenaderm Marketing

By Sherry Mazzocchi · April 1, 2011, 7:13 PM EDT

The U.S. Department of Justice on Thursday accused Healthpoint Ltd. of falsely marketing the bedsore ointment Xenaderm as a prescription drug qualifying for Medicare and Medicaid reimbursement, causing the agencies to...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

complaint

Case Information

Case Title

United States, ex rel v. Actavis Mid-Atlantic, et al

Case Number

Court

Massachusetts

Nature of Suit

Other Statutory Actions

Date Filed

August 29, 2002

Recent Articles By Sherry

April 15, 2011
FDA Issues Safety Warning On Teva's Generic Prevacid
April 13, 2011
FDA Warns Philips Over Fatal Defibrillator Defects
April 08, 2011
Nautilus Sues Wockhardt Over Cambia ANDA
March 28, 2011
Cephalon Loses Bid For Quick Win In Marketing Suit
March 25, 2011
Medtronic Unit Must Face Antitrust Claims: Judge
March 25, 2011
Fla. House Committee OKs Malpractice Cap Bill
March 24, 2011
Vermont House Approves Single-Payer Health Care Bill
March 10, 2011
HHS Proposes New State Health Care Waiver Rules
March 07, 2011
BNY, Wells Fargo OK'd To Intervene In $21M Ponzi Deal
March 07, 2011
Gibson Dunn Reps Accuray In $277M Radiotherapy Deal